Researchers are studying compounds found in mushrooms for possible roles in cancer prevention and depression treatment, but evidence varies and does not establish that eating mushrooms can treat either condition.
Mushrooms have long been valued for their flavour and nutritional content, but scientists are still investigating whether compounds found in them can help prevent disease or improve mental health.
Edible mushrooms contain nutrients and bioactive compounds, including ergothioneine and glutathione, which have antioxidant properties. However, laboratory evidence of antioxidant activity does not automatically mean that eating mushrooms prevents disease in humans.
Their potential health effects have attracted research interest in cancer, depression and metabolic health, although the strength of evidence differs across these areas.
Cancer research points to an association, not proof of prevention
A systematic review and meta-analysis published in Advances in Nutrition in 2021 examined 17 observational studies involving nearly 20,000 cancer cases.
The researchers found that people reporting higher mushroom consumption tended to have a lower risk of cancer, particularly breast cancer. The pooled analysis found a 35 percent lower relative risk of breast cancer among people in the highest consumption groups compared with those in the lowest groups.
The findings do not establish that mushrooms caused the lower risk. Most of the studies included in the review were observational, meaning researchers examined existing dietary habits and health outcomes rather than assigning participants to eat mushrooms or avoid them.
The researchers also identified differences between studies, including variations in study design and the populations examined. They called for larger prospective studies to establish whether the association reflects a protective effect.
Scientists are investigating compounds in mushrooms that may influence biological processes linked to cancer. But claims that mushrooms prevent cancer, or that a particular daily serving provides a guaranteed reduction in risk, go beyond the available evidence.
Psilocybin research and depression
Research into mushrooms and mental health involves a separate question: whether psilocybin, a psychedelic compound found in some mushroom species, could have a role in treating depression.
Psilocybin affects the brain’s serotonin system, which is involved in mood and other functions. Researchers are investigating its use alongside psychological support, particularly for people whose depression has not responded to standard treatments.
A randomised trial published in Nature Medicine in August 2026 examined psilocybin-assisted therapy in 60 people with treatment-resistant depression in England. Participants received either psilocybin or a placebo, with psychological support provided to both groups.
The study found a greater reduction in depression scores among those who received psilocybin, with the difference remaining at the six-week follow-up. The researchers said the results support further trials to establish the treatment’s effectiveness and safety.
The findings do not mean that eating ordinary mushrooms treats depression. The trial used a controlled dose of psilocybin in a clinical research setting, with medical and psychological support.
Psilocybin remains an investigational treatment in this context. It should not be confused with established depression treatments or used without appropriate medical supervision.
Nutrients and dietary value
Edible mushrooms provide several nutrients, including potassium, copper, phosphorus and B vitamins. Their nutritional composition varies by species and growing conditions.
Some mushrooms also contain vitamin D, particularly when exposed to ultraviolet light. A review of research on white button mushrooms found that UVB-exposed varieties could improve vitamin D status in humans, although the amount present depends on how the mushrooms are produced and prepared.
Potassium helps regulate blood pressure and supports normal nerve and muscle function. Mushrooms can contribute to dietary potassium intake, but their contribution varies by variety and serving size. The US National Institutes of Health lists adequate daily intakes of 3,000 milligrams for males aged 14 to 18 and 2,300 milligrams for females in the same age group.
Mushrooms also contain dietary fibre, including compounds such as beta-glucans. Researchers are studying their possible effects on immune function and metabolic health, but evidence from laboratory and animal studies does not always translate into demonstrated benefits in people.
Their relatively low energy content and ability to add flavour and texture to meals can make them a useful part of a varied diet. They provide some protein, but the amount differs by species and preparation.
Skin, hair and ageing claims need more evidence
Mushroom extracts are used in some skin-care and cosmetic products because they contain compounds being investigated for antioxidant and anti-inflammatory activity.
However, evidence that these products slow visible ageing or produce lasting improvements in skin health remains limited. The presence of an antioxidant in a mushroom does not, on its own, establish that applying its extract to the skin will produce a measurable benefit.
Claims that eating mushrooms delays grey hair or that reishi extracts improve circulation to the scalp and prevent hair loss also require stronger clinical evidence. Copper contributes to normal physiological processes, but that does not demonstrate that mushroom consumption prevents greying.
Consumers should therefore distinguish between the established nutritional value of edible mushrooms and marketing claims about specific beauty or anti-ageing effects.
Mushrooms can contribute to a balanced diet, but they are not a substitute for cancer screening, medical assessment or evidence-based treatment for depression. Further research is needed to determine which of their compounds produce meaningful health benefits in humans and under what conditions.
